Powered By
Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more
Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more
Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for use before autologous stem cell transplant in people with non-Hodgkin lymphoma and multiple myeloma. Mozobil is used in… read more
Overview
Lunsumio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory follicular lymphoma who have already tried two types of systemic therapy.… read more
Overview
Epkinly is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, in adults who have already… read more
Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Kymriah is indicated when lymphoma is relapsed or refractory and at least two… read more
Overview
Yescarta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Yescarta is indicated when lymphoma is relapsed or refractory and at least two… read more
Overview
Breyanzi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL)…
Join